
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
Adrian Wildfire is project director, Infectious Diseases &Viral Challenge Unit, SGS Life SciencesâClinical Research.
Published: November 15th 2017 | Updated: